⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL127780 | 0.81 | — | — | |
| SCHEMBL2166892 | 0.80 | — | — | |
| SCHEMBL271848 | 0.80 | GAA (0.50) | — | |
| SCHEMBL5491842 | 0.79 | — | — | |
| SCHEMBL28019222 | 0.77 | — | — | |
| SCHEMBL28034471 | 0.77 | — | — | |
| SCHEMBL27617288 | 0.77 | CA2 (0.59) | — | |
| SCHEMBL6988170 | 0.77 | L3MBTL1 (0.50) | — | |
| SCHEMBL128278 | 0.75 | TSHR (0.40) | — | |
| SCHEMBL6044927 | 0.75 | KMT2A (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100475829-C | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents | SCHERING CORP (US) | 2009-04-08 | — | — | CN | claimed |
| US-6982251-B2 | Substituted 2-azetidinones useful as hypocholesterolemic agents | SCHERING CORPORATION (US) | 2006-01-03 | — | — | US | claimed |
| EP-1510521-A1 | Sugar-substituted 2-Azetidinones useful as hypocholesterolemic agents | Schering Corporation (US) | 2005-03-02 | — | — | EP | claimed |
| EP-1347987-B1 | SUGAR-SUBSTITUTED 2-AZETIDINONES USEFUL AS HYPOCHOLESTEROLEMIC AGENTS | SCHERING CORP (US) | 2004-10-13 | — | — | EP | claimed |
| CN-1483039-A | Sugar-substituted 2-azetidinones as hypocholesterolemic agents | ���鹫˾ | 2004-03-17 | — | — | CN | claimed |
| EP-1347987-A1 | SUGAR-SUBSTITUTED 2-AZETIDINONES USEFUL AS HYPOCHOLESTEROLEMIC AGENTS | Schering Corporation (US) | 2003-10-01 | — | — | EP | claimed |
| US-20030105028-A1 | Substituted 2-azetidinones useful as hypocholesterolemic agents | SCHERING CORPORATION | 2003-06-05 | — | — | US | claimed |
| US-20020137690-A1 | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents | SCHERING CORPORATION | 2002-09-26 | — | — | US | claimed |
| WO-2002050090-A1 | SUGAR-SUBSTITUTED 2-AZETIDINONES USEFUL AS HYPOCHOLESTEROLEMIC AGENTS | SCHERING CORPORATION (US) | 2002-06-27 | — | — | WO | claimed |
| US-5939398-A | ANTIATHEROSCLEROSIS AGENTS | PFIZER INC. (US) | 1999-08-17 | — | — | US | claimed |
| US-5756470-A | ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS | SCHERING CORPORATION (US) | 1998-05-26 | — | — | US | claimed |
| US-5698526-A | ANTICHOLESTEROL AGENT | PFIZER INC. (US) | 1997-12-16 | — | — | US | claimed |
| EP-0737203-A1 | STEROIDAL GLYCOSIDES | PFIZER INC. (US) | 1996-10-16 | — | — | EP | claimed |
| EP-0737202-A1 | HYPOCHOLESTEROLEMIC AGENTS | PFIZER INC. (US) | 1996-10-16 | — | — | EP | claimed |
| WO-1995018143-A1 | HYPOCHOLESTEROLEMIC AGENTS | PFIZER INC. (US) | 1995-07-06 | — | — | WO | claimed |
| WO-1995018144-A1 | STEROIDAL GLYCOSIDES | PFIZER INC. (US) | 1995-07-06 | — | — | WO | claimed |
| US-20230125434-A1 | METHOD FOR PRODUCING MONOSULFOXIDE DERIVATIVE | KUMIAI CHEMICAL INDUSTRY CO. LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-4144723-A1 | METHOD FOR PRODUCING MONOSULFOXIDE DERIVATIVE | Kumiai Chemical Industry Co., Ltd. (JP) | 2023-03-08 | — | — | EP | disclosed |
| EP-0108709-A2 | Polyalkyl piperidines | CIBA-GEIGY AG (CH) | 1984-05-16 | — | — | EP | disclosed |
| US-4211696-A | Disperse monoazo dyestuffs derived from 3,5-dinitro-2-amino thiophene as disazo component and an arylamine coupling component | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-07-08 | — | — | US | disclosed |